enbn_01

enbn_01

enxxx2

enxxx2

ennewbn

ennewbn

11
joincare

ABOUT US

Our company was founded on December 18, 1992 and listed on the Shanghai Stock Exchange in June 2001. After years of business development, it has become a comprehensive group company integrating the research and development, production, sales and service of medicine and health products, with more than 500 varieties of products in various fields such as health products, Chinese patent medicines, testing reagents, monoclonal antibodies, APIs and chemical preparations. The Group has more than 30 major holding subsidiaries and more than 10,000 employees. As of the end of 2018, the company's total assets amounted to RMB 24.986 billion and the operating income was RMB 11.204 billion.

More

NEWS

“MSCI inclusion” and “FTSE inclusion” (the FTSE GEIS Index)
js_thumb

Time Posted31

Time Posted2019-05

In the early morning of May 25, Beijing time, FTSE Russell, the world’s second largest index company, announced the first batch of A-shares included in its index system. The list covers the large
 See details
In the early morning of May 25, Beijing time, FTSE Russell, the world’s second largest index company, announced the first batch of A-shares included in its index system. The list covers the large
One inhalation solution drug of Joincare obtained registration approval
js_thumb

Time Posted29

Time Posted2019-05

Shanghai Securities News and cnstock news 
 See details
Shanghai Securities News and cnstock news 
Time-honored Confidence in Traditional Medicine: Ginseng Antiphlogistic Capsule Has an Outstanding Effect on Curing Plague

Time Posted23

Time Posted2020-03

Proposed by Application of GAP, the medicine can treat all kinds of influenzas. Ginseng prevents patients from organ failure. 
 See details
Proposed by Application of GAP, the medicine can treat all kinds of influenzas. Ginseng prevents patients from organ failure. 
Zheng Yuan Dan,Seasonal Flu Prevention:Ginseng antiphlogistic powder,a exclusive health strategy for you

Time Posted23

Time Posted2020-03

As the situation of battling with COVID-19 in China has gradually gotten better, China turns to offer support to other countries in need after receiving friendly assistance from countries. 
 See details
As the situation of battling with COVID-19 in China has gradually gotten better, China turns to offer support to other countries in need after receiving friendly assistance from countries. 
Abating fever caused by NCV with a half dose of medicine: TCM saved my life!

Time Posted23

Time Posted2020-03

The NCV outbreaking recently is a serious public health emergency. Its fastest, broadest contagion has brought about the more difficulty in its prevention than ever since the foundation of China.
 See details
The NCV outbreaking recently is a serious public health emergency. Its fastest, broadest contagion has brought about the more difficulty in its prevention than ever since the foundation of China.
Donated 22 million yuan to fight against the COVID-19 outbreak, Joincare and Livzon Group practiced social responsibility

Time Posted20

Time Posted2020-03

 According to public information, in the face of multiple disasters in China, Joincare Group and Livzon Group have made contributions in an active stance, and gave a helping hand.
 See details
 According to public information, in the face of multiple disasters in China, Joincare Group and Livzon Group have made contributions in an active stance, and gave a helping hand.
More

OUR BUSINESS

SEARCH FOR THE PRODUCTS YOU NEED

Search
1

Corporate Social Responsibility

More
1

Investor Relations

More
1

Job Opportunities

Service Hotline

0755-86252388

Copyright © Joincare Pharmaceutical Group Industry Co., Ltd. All Rights Reserved.  Powered by:www.300.cn Zhuhai